Related references
Note: Only part of the references are listed.Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee
Katherine E. Warren et al.
NEURO-ONCOLOGY (2018)
Leptomeningeal metastases: a RANO proposal for response criteria
Marc Chamberlain et al.
NEURO-ONCOLOGY (2017)
Palliative lumboperitoneal shunt for leptomeningeal metastasis-related hydrocephalus: A case series
Shigeo Yamashiro et al.
PALLIATIVE MEDICINE (2017)
Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases
Amparo Wolf et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis
Nayan Lamba et al.
RADIATION ONCOLOGY (2017)
Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis after Resection of Brain Metastases in Breast Cancer Patients
Boram Ha et al.
CANCER RESEARCH AND TREATMENT (2017)
Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial
Jin-Ji Yang et al.
LANCET RESPIRATORY MEDICINE (2017)
Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study
Akihiro Tamiya et al.
ANTICANCER RESEARCH (2017)
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
Javier Cortes et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Efficacy of bevacizumab and erlotinib combination for leptomeningeal carcinomatosis after failure of erlotinib
Ryo Ariyasu et al.
ANTI-CANCER DRUGS (2017)
Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis
Adrienne Boire et al.
CELL (2017)
Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer
C. Rothermundt et al.
ANNALS OF ONCOLOGY (2016)
EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors
Bojana Milojkovic Kerklaan et al.
NEURO-ONCOLOGY (2016)
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
Kerry J. Savage et al.
BLOOD (2016)
Osimertinib (AZD9291) and CNS Response in Two Radiotherapy-Naive Patients with EGFR-Mutant and T790M-Positive Advanced Non-Small Cell Lung Cancer
Biagio Ricciuti et al.
CLINICAL DRUG INVESTIGATION (2016)
Leptomeningeal metastases of solid cancer
Emilie Le Rhun et al.
CURRENT OPINION IN NEUROLOGY (2016)
Nimotuzumab treatment and outcome analysis in patients with leptomeningeal metastasis from nonsmall cell lung cancer
Yanfang Ju et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)
Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer
Shirish M. Gadgeel et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
Norbert Schmitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
Sarah B. Goldberg et al.
LANCET ONCOLOGY (2016)
Erlotinib plus bevacizumab as an effective treatment for leptomeningeal metastases from EGFR mutation-positive non-small cell lung cancer
Yoshihiko Sakata et al.
LUNG CANCER (2016)
Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors
Michael C. Burger et al.
PLOS ONE (2016)
Durable Clinical Benefit of Pertuzumab in a Young Patient with BRCA2 Mutation and HER2-Overexpressing Breast Cancer Involving the Brain
Anna Koumarianou et al.
CASE REPORTS IN ONCOLOGICAL MEDICINE (2016)
Proton therapy and helical tomotherapy result in reduced dose deposition to the pancreas in the setting of cranio-spinal irradiation for medulloblastoma: Implications for reduced risk of diabetes mellitus in long-term survivors
Jeffrey V. Brower et al.
ACTA ONCOLOGICA (2015)
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer
Lakshmi Nayak et al.
CANCER (2015)
Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis
D. Subira et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Activity of T-DM1 in Her2-positive breast cancer brain metastases
Rupert Bartsch et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing from Whole-Brain Radiotherapy
Yen-Shen Lu et al.
CLINICAL CANCER RESEARCH (2015)
Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis
Frank Mu et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Intravenous thiotepa for treatment of breast cancer-related leptomeningeal carcinomatosis: case series
Jaspreet Chahal et al.
NEUROLOGICAL SCIENCES (2015)
A Phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer
David M. Jackman et al.
ONCOTARGET (2015)
Surgical Ventricular Entry is a Key Risk Factor for Leptomeningeal Metastasis of High Grade Gliomas
Roland Roelz et al.
SCIENTIFIC REPORTS (2015)
Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
I. E. Krop et al.
ANNALS OF ONCOLOGY (2015)
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
A. M. Di Giacomo et al.
ANNALS OF ONCOLOGY (2015)
A Phase II Trial of Capecitabine Concomitantly With Whole-Brain Radiotherapy Followed by Capecitabine and Sunitinib for Brain Metastases From Breast Cancer
Polly Niravath et al.
ONCOLOGIST (2015)
Brain Metastases from Breast Cancer and Response to Treatment with Eribulin: A Case Series
Alex Y. Chang et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2015)
Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study
Reinhard Dummer et al.
EUROPEAN JOURNAL OF CANCER (2014)
A New Treatment Paradigm: Neoadjuvant Radiosurgery Before Surgical Resection of Brain Metastases With Analysis of Local Tumor Recurrence
Anthony L. Asher et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Triple Intrathecal Therapy Alone With Omission of Cranial Radiation in Children With Acute Lymphoblastic Leukemia
Hsi-Che Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Use of liposomal doxorubicin-cyclophosphamide combination in breast cancer patients with brain metastases: a monocentric retrospective study
B. Linot et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study
Brian J. Scott et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases; a Preferential Option for Triple Negative Patients?
Cigdem Erten et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis
Flora Zagouri et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Proton Beam Craniospinal Irradiation Reduces Acute Toxicity for Adults With Medulloblastoma
Aaron P. Brown et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Prolonged Survival of a Patient With Papillary Renal Cell Carcinoma and Brain Metastases Using Pazopanib
Corbin Jacobs et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)
James L. Rubenstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases
Priya Kumthekar et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Thomas Bachelot et al.
LANCET ONCOLOGY (2013)
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
Paul D. Brown et al.
NEURO-ONCOLOGY (2013)
Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience
P. Gaviani et al.
NEUROLOGICAL SCIENCES (2013)
Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors
Lakshmi Nayak et al.
NEUROLOGY (2013)
Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine- DNA Methyltransferase as a Potential Biomarker
M. Catherine Pietanza et al.
CLINICAL CANCER RESEARCH (2012)
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Kim Margolin et al.
LANCET ONCOLOGY (2012)
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
Georgina V. Long et al.
LANCET ONCOLOGY (2012)
Upfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinoma
Olivier Bailon et al.
NEURO-ONCOLOGY (2012)
Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)
F. Barlesi et al.
ANNALS OF ONCOLOGY (2011)
Pulsatile high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer
Christian Grommes et al.
NEURO-ONCOLOGY (2011)
Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study
S. Siena et al.
ANNALS OF ONCOLOGY (2010)
Isolated Loss of Hormonal Receptors in Leptomeningeal Metastasis From Estrogen Receptor- and Progesterone Receptor-Positive Lobular Breast Cancer
Jai Grewal et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The imaging and neuropathological effects of Bevacizumab (Avastin) in patients with leptomeningeal carcinomatosis
B. K. Kleinschmidt-DeMasters et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
A Case of Brain Metastases from Breast Cancer that Responded to Anastrozole Monotherapy
Ken-ichi Ito et al.
BREAST JOURNAL (2009)
Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C
Marc C. Chamberlain et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma
Luis Villela et al.
ANTI-CANCER DRUGS (2008)
Chemotherapy for brain metastases in small-cell lung cancer
Gigi Chen et al.
CLINICAL LUNG CANCER (2008)
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies
Morris D. Groves et al.
NEURO-ONCOLOGY (2008)
Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy
T Seute et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis
MC Chamberlain et al.
CANCER (2006)
Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection
M Ozdogan et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2003)
Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: A report of NABTT 96-07
T Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: Methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone
DY Kim et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2003)
Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation: a multicentre phase II study
A Korfel et al.
EUROPEAN JOURNAL OF CANCER (2002)
A phase II trial of intra-cerebrospinal fluid alpha interferon in the treatment of neoplastic meningitis
MC Chamberlain
CANCER (2002)
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine
KA Jaeckle et al.
BRITISH JOURNAL OF CANCER (2001)
Response of leptomeningeal metastases from breast cancer to hormonal therapy
W Boogerd et al.
NEUROLOGY (2000)
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis
ML Tetef et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2000)
Share Paper
